Adam McDonald, DPM
Foot & Ankle Surgery · Greensboro, NCNPI 1659727311
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,269 of the $6,872 with a category attached, or 62.1%. 29 manufacturers reported payments, led by Stryker at 27.7% of the total. 2025 is the largest year on record at $2,545, more than ten times the $91 reported in 2019.
Across 98 payments — averaging $70.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Treace Medical Concepts, Inc.$2K
- Arthrex$485
- Smith+Nephew$363
- Medshape, Inc.$339
- Piedmont Plus Innovation$329
- plus $2K from 23 others
What the payments were for
- Travel & lodging$2,58538%
- Food & beverage$4,26962%
- Entertainment$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 15 | $1,904 |
| Treace Medical Concepts, Inc. | 12 | $1,622 |
| Arthrex | 7 | $485 |
| Smith+Nephew | 12 | $363 |
| Medshape, Inc. | 2 | $339 |
| Piedmont Plus Innovation | 3 | $329 |
| Organogenesis Inc. | 5 | $272 |
| Kerecis Limited | 6 | $251 |
| Bioventus LLC | 3 | $190 |
| Polynovo North America LLC | 1 | $182 |
| Convatec Inc. | 4 | $177 |
| Averitas Pharma Inc. | 6 | $164 |
| Johnson & Johnson | 2 | $93 |
| Integra Lifesciences Corporation | 1 | $77 |
| Paragon 28, Inc. | 1 | $76 |
| AbbVie | 4 | $73 |
| Next Science LLC | 2 | $37 |
| Vertex | 1 | $28 |
| Fusion Orthopedics USA, LLC | 1 | $27 |
| Medline Industries LP | 1 | $26 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $24 |
| GRT US Holding, Inc. | 1 | $21 |
| Amgen | 1 | $18 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $18 |
| KCI USA, Inc. | 1 | $17 |
| Access Pro Medical, LLC | 1 | $16 |
| Biocomposites Inc | 1 | $15 |
| Medtronic | 1 | $15 |
| Boston Scientific | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRIME SERIES$921
- LAPIPLASTY SYSTEM 1$398
- Lapiplasty System$372
- Lapiplasty$340
- DynaNail$339
- AUGMENT INJECTABLE$265
- PROPHECY$205
- DynaNail Helix, Washer, 15 mm$190
- Novosorb BTM$182
- HOFFMANN$171
- CITREFIX$171
- Exogen Ultrasound Bone Healing System$138
- GRAFIX PL$133
- Oasis$133
- Stravix$133
- InnovaMatrix AC$114
- PuraPly$107
- TMC NANOPLASTY SYSTEM$101
How this compares
$6,872 in reported general payments places this provider in the 70th percentile of 196 foot & ankle surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 12 | $3,648 |
| Ketoconazole | 69 | $1,794 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 28 | $1,597 |
| Gentamicin Sulfate | 36 | $1,461 |
| Terbinafine Hcl | 62 | $1,394 |
| Gabapentin | 111 | $1,377 |
| Fluconazole | 29 | $742 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 39 | $723 |
| Mupirocin | 79 | $678 |
| Ciclopirox | 24 | $577 |
| Doxycycline Hyclate | 54 | $575 |
| Diclofenac Sodium | 41 | $540 |
| Cephalexin | 57 | $406 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 19 | $354 |
| Lidocaine | 12 | $283 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $363 | $3,64812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 196 foot & ankle surgery providers in North Carolina.
Other foot & ankle surgery in Greensboro
- Andrew RegalGreensboro$10K
- Brent EvansGreensboro$6K
- Robert OlsonGastonia$473K
- Austin MatthewsLumberton$279K
- Matthew DzurikWilmington$142K
- Kristen McGinnessFayetteville$123K
- William RespessGreenville$79K
- Brian FutrellCary$71K
- Kenneth BloomMooresville$53K
- Stephen HeislerChapel Hill$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.